Rare genetic disorders

Thursday, May 2, 2019: 5:30 PM-7:00 PM
Room: 710 (Palais des congres de Montreal)
5:30 PM
224 Links between Autism and the FMR1 Premutation: Insights from Studies of Gaze, Language, and Cognition in Carriers of the FMR1 Premutation
K. Nayar M. Winston A. L. Hogan W. S. McKinney G. E. Martin J. N. Barstein C. G. La Valle M. Losh
5:30 PM
5:30 PM
226 A Comparison of Head Circumference Growth Trajectories in the Context of the CHD8 Regulatory Network
B. M. Boyd A. B. Arnett C. M. Hudac K. Hoekzema T. Turner B. J. O'Roak E. E. Eichler R. Bernier
5:30 PM
Altered Striatum Centered Connectivity in SHANK3-Deficient Patients (Withdrawn)
C. Liu X. Xu D. Li
5:30 PM
229 Data Harmonization across Genetic Conditions Associated with Autism
A. Halladay H. Grosman J. Acampado J. Tjernagel
5:30 PM
231 Early Development and ASD Risk in Neurofibromatosis Type 1
A. Kolesnik E. J. Jones J. Begum Ali S. Garg T. Charman J. Green M. H. Johnson
5:30 PM
232 Effects of Age, Gender, and Genotype on Auditory Processing in Phelan-Mcdermid Syndrome
M. Reese E. Berry-Kravis A. Thaliath E. Isenstein A. R. Durkin J. Foss-Feig P. M. Siper C. A. Nelson L. M. Baczewski A. R. Levin C. M. Powell S. P. White M. W. Mosconi A. Kolevzon L. E. Ethridge
5:30 PM
233 Electrophysiological Biomarkers of Sensory Processing Alterations in Idiopathic and Single-Gene Causes of ASD
M. A. Rowe J. George-Jones E. Isenstein H. Grosman S. Guillory Y. Zhang S. M. Lurie C. McLaughlin L. Tang I. Giserman-Kiss J. Foss-Feig P. M. Siper
5:30 PM
236 Genotype-Phenotype Correlations in Phelan-Mcdermid Syndrome
A. Ricciardello F. Cucinotta L. Turriziani M. Briguglio M. Boncoddo F. Bellomo G. Turturo P. Tomaiuolo M. Baccarin C. Picinelli P. Castronovo C. Lintas R. Sacco A. M. Persico
5:30 PM
237 Language and Motor Development in Children with Adnp Syndrome
L. Tang I. Giserman-Kiss M. Mulhern D. Halpern J. Zweifach J. Foss-Feig H. Voulgarakis M. A. Rowe A. R. Durkin J. Buxbaum A. Kolevzon S. De Rubeis P. M. Siper
5:30 PM
238 Medical Issues in Ehlers-Danlos Syndrome/Hypermobility Spectrum Disorders, Autism Spectrum Disorder, and Unaffected Controls
E. L. Casanova J. L. Sharp S. M. Edelson D. P. Kelly E. M. Sokhadze M. Casanova
5:30 PM
241 Neuropsychiatric Phenotypes in 3q29 Deletion Syndrome and Novel Features of ASD: Results from the 3q29 Registry
R. M. Pollak M. M. Murphy M. P. Epstein M. E. Zwick C. Klaiman C. A. Saulnier J. G. Mulle
5:30 PM
242 Predictors of Psychotic Symptoms Among 16p11.2 Copy Number Variant Carriers
A. Jutla J. Veenstra-Vander Weele W. K. Chung
5:30 PM
243 Restricted Repetitive Behaviors of Individuals with Comorbid Tuberous Sclerosis Complex and Autism Spectrum Disorder
H. K. Root S. E. O'Kelley M. Bebin H. Northrup J. Wu D. A. Krueger M. Sahin
5:30 PM
245 The Neurocognitive Profile of Individuals with Phelan Mcdermid Syndrome (PMS): Comparison with Autism Spectrum Disorder (ASD) and Individual Differences.
J. Cooke A. San Jose Caceres L. Mason E. J. Jones D. V. Crawley H. L. Hayward B. Oakley J. Ahmad C. L. Ellis M. Nunez D. G. Murphy E. Loth
5:30 PM
246 Understanding the Landscape of Behavioral Interventions for Individuals with Phelan-Mcdermid Syndrome
A. Wainer M. Printen C. Leonczyk E. Berry-Kravis J. Buxbaum G. Bliss L. Soorya
See more of: Rare Genetic Disorders